Effect and underlying mechanism of liraglutide on fibroblast growth factor-21 production in mouse islet β cells
Lina Ge,Rui Wei,Kun Yang,Jin Yang,Tianpei Hong
DOI: https://doi.org/10.3760/cma.j.issn.1674-5809.2018.02.009
2018-01-01
Abstract:Objective To investigate the effect and potential mechanism of glucagon-like peptide-1(GLP-1)receptor agonist liraglutide on fibroblast growth factor-21(FGF-21)production in mouse pancreatic β cell line Min6.Methods Min6 cells were incubated for 24 h with liraglutide in the presence or absence of the GLP-1 receptor antagonist exendin(9-39).The expressions of FGF-21 mRNA and protein were detected by RT-PCR and western blotting analyses. Supernatant FGF-21 levels were measured by ELISA. In the mean time, after Min6 cells were incubated with 10 nmol/L liraglutide and/or 5 μg/ml neutralizing anti-FGF-21 IgG for 24 h,supernatant insulin levels were measured by ELISA.Different group comparisons were performed using one-way variance analysis and LSD-t test. Results Compared with control group, 1, 10 and 100 nmol/L liraglutide dose-dependently upreglulated the expression levels of FGF-21 mRNA (1.26 ± 0.24,1.52 ± 0.41 and 1.21 ± 0.26 vs 1, F=3.523, P=0.021) and protein (1.61 ± 0.27, 1.70±0.45 and 1.27±0.10 vs 1,F=5.052,P=0.006),and increased the levels of FGF-21 secretion[(0.21± 0.05), (0.25 ± 0.08) and (0.26 ± 0.07) vs (0.19 ± 0.06) μg/mg, F=16.44,P=0.007] in Min6 cells. The above effects of 10 nmol/L liraglutide could be eliminated by addition of exendin(9-39)[mRNA level,0.85±0.15 vs 1.31 ± 0.16, t=4.133, P=0.026; protein level, 1.27 ± 0.13 vs 1.74 ± 0.06, t=10.55, P=0.009; secretion level,(0.23±0.11)vs(0.26±0.10)μg/mg protein, t=4.159,P=0.025].Moreover,compared with control group, 10 nmol/L liraglutide stimulated insulin secretion in Min6 cells[(1.22 ± 0.47)vs(0.55 ± 0.23)μg/mg protein,t=3.19,P=0.024],which could be abolished by blocking FGF-21 action with anti-FGF-21 IgG[(0.67± 0.28)vs (1.22 ± 0.47)μg/mg protein, t=4.371, P=0.007]. Conclusion Liraglutide enhances FGF-21 production in mouse pancreatic β cell line Min6 in a GLP-1 receptor-dependent manner.FGF-21 may be involved in the stimulating effect of liraglutide on insulin secretion from Min6 cells in an autocrine or paracrine fashion.
What problem does this paper attempt to address?